Pathophysiological findings of early mind harm in people haven’t permitted conclusive determinations. We explored the essence of this phenomenon by taking intraoperative cortical specimens of Hunt-Kosnik grades IV~V (poor-grade) subarachnoid hemorrhages (SAH). From 2013 to 2017, we handled 39 consecutive poor-grade sufferers in 226 instances of aneurysmal SAH. Fourteen of the 39 sufferers agreed to this examine following written knowledgeable consent. We took specimens from untouched areas previous to surgical intervention: cortex close to the ruptured aneurysm for clipping, convexity cortex for cerebral ventricular drainage. Cortical specimens have been stained with hematoxylin-eosin, anti-cleaved <em>caspase</em>-3, and anti-DNA/RNA injury staining. Optimistic alerts have been calculated in six random, high-power fields for quantitative evaluation.
Double immunofluorescence was finished to judge neural injury. Chi-square analyses have been carried out to evaluate the correlation between the Glasgow End result Scale at 90 days after the ictus and the variety of constructive cells. Cortical specimens have been taken at 12.7 ± 7.00 h after the primary ictus. All <em>14</em> instances confirmed dense nuclei, with the looks of acidic and shrunken cytoplasms. Diffuse positivity of anti-cleaved <em>caspase</em>-Three and anti-DNA/RNA injury was detected. Cleaved <em>caspase</em>-Three was detected in 68% of neurons, and DNA/RNA injury was detected in 64% of neurons. Optimistic reactions of each antibodies indicated poor consequence.
With poor-grade instances, irreversible ischemic, apoptotic, and oxidative adjustments have been detected within the cerebral cortex inside a number of hours after the ictus. These adjustments occurred removed from the aneurysm. Our findings recommend {that a} revolution is required within the remedy technique for poor-grade SAH.
Thymus algeriensis and Thymus fontanesii exert neuroprotective impact towards power constriction injury-induced neuropathic ache in rats
We’ve beforehand demonstrated that the Thymus algeriensis and Thymus fontanesii extracts have highly effective anti-inflammatory, antipyretic, and analgesic results towards acute ache fashions. We profiled their chemical composition and located many phenolic acids, flavonoids, and phenolic diterpenes. On this work, we investigated their antioxidant properties on HaCaT cells uncovered to UVA-induced oxidative stress and examined their results towards power neuropathic ache and the underlying mechanisms. Via a rat power constriction harm (CCI) mannequin, we induced power neuropathic ache by inserting Four unfastened ligatures round the precise sciatic nerve for <em>14</em> days. Thermal and mechanical hyperalgesia along with chilly and dynamic allodynia have been examined on the day earlier than surgical procedure and on the seventh and <em>14</em>th post-surgery days.
Key markers of the nitrosative and oxidative stresses, along with markers of irritation, have been measured at day <em>14</em> submit surgical procedure. Histopathological examination and immunostaining of each synaptophysin and <em>caspase</em>-Three of sciatic nerve and mind stem have been additionally carried out. Outcomes of this examine confirmed that T. algeriensis extract suppresses UVA oxidative stress in HaCaT cells through activation of the Nrf-2 pathway. Each extracts attenuated hyperalgesia and allodynia at 7- and <em>14</em>-days post-surgery with extra distinguished results at day <em>14</em> of surgical procedure. Their protecting results towards neuropathic ache have been mediated by inhibiting NOX-1, iNOS, by growing the enzyme exercise of catalase, and inhibition of inflammatory mediators, NF-κB, TNF-α, lipoxygenase, COX-2 enzymes, and PGE2.
Moreover, they improved deleterious structural adjustments of the brainstem and sciatic nerve. Additionally they attenuated the elevated <em>caspase</em>-Three and synaptophysin. The info point out that each extracts have neuroprotective results towards power constriction injury-induced neuropathic ache. The noticed protecting results are partially mediated by means of attenuation of oxidative and nitrosative stress and suppression of each neuroinflammation and neuronal apoptosis, suggesting substantial actions of each extracts in amelioration of painful peripheral neuropathy.
Irreversible Neuronal Damage Begins Just After Aneurysm Rupture in Poor-Grade Subarachnoid Hemorrhage Patients
Results of gestational publicity to perfluorooctane sulfonate on the lung growth of offspring rats
Perfluorooctane sulfonate (PFOS) is a man-made fluorosurfactant broadly utilized in business and client merchandise. Earlier research with rats instructed that gestational publicity to PFOS could have an effect on the lung growth within the offspring. The mechanism, nevertheless, continues to be unknown. Within the current examine, we’ve uncovered 24 pregnant SD rats from gestational day 12-18 to totally different doses of PFOS (0, 1 or 5 mg/kg BW/day). The lungs of the offspring have been analyzed at postnatal days 1, 3, 7 and <em>14</em>. PFOS remedy appeared to cut back the alveolar numbers, leading to simplified alveolar construction and thickened alveolar septa. Additionally, PFOS handled animals had elevated lung irritation with up-regulated inflammasome related proteins NLRP3, ASC, <em>Caspase</em>-1 and GSDMD and elevated inflammatory cytokines IL-18 and IL-1β.
On the similar time, HIF-1α and VEGFA have been considerably down-regulated. Since HIF-1α and VEGFA are essential components selling alveolar growth and pulmonary angiogenesis, these outcomes instructed that PFOS can also have an effect on lung growth by inhibiting HIF-1α and VEGFA expression. Our outcomes right here point out that gestational publicity to PFOS could have an effect on lung growth within the offspring with pathological traits just like bronchopulmonary dysplasia (BPD), a extreme lung developmental defect. The outcomes additionally recommend that environmental components equivalent to PFOS could contribute to the growing incidence of developmental lung ailments, equivalent to BPD, by elevating lung irritation and inhibiting lung growth.
Adversarial results of fetal publicity of electronic-cigarettes and high-fat weight loss plan on male neonatal hearts
Epidemiological research have proven an elevated threat of cardiovascular ailments in kids born to moms who smoked throughout being pregnant. The cardiovascular threat within the offspring related to in utero nicotine publicity is additional exaggerated by maternal weight problems. The consumption of digital cigarettes (e-cigarettes) is alarmingly growing amongst adolescents and younger adults with out the information of their dangerous well being results. There has additionally been a considerable enhance in e-cigarette use by ladies of reproductive age. This examine investigates the detrimental results of gestational publicity of e-cigarette and a high-fat weight loss plan (HFD) on neonatal hearts.
Time-mated pregnant mice have been fed a HFD and uncovered to saline or e-cigarette aerosol with 2.4% nicotine from embryonic day 4 (E4) to E20. We demonstrated that in utero publicity of e-cigarettes and HFD from E4 to E20 triggers cardiomyocyte (CM) apoptosis within the offspring at postnatal day1 (PND1), PND3, and PND<em>14</em>. Induction of CM apoptosis following gestational publicity of e-cigarettes and HFD was related to inactivation of AMP-activated protein kinase (AMPK), elevated cardiac oxidative stress coupled with perturbation of cardiac BAX/BCL-2 ratio and activation of <em>caspase</em> Three at PND <em>14</em>.
Caspase 14 Antibody |
MBS9233173-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
Caspase 14 antibody |
MBS9410712-01mL |
MyBiosource |
0.1mL |
EUR 420 |
Caspase 14 antibody |
MBS9410712-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1740 |
Caspase-14 Antibody |
24157-100ul |
SAB |
100ul |
EUR 468 |
Caspase-14 Antibody |
2509-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Caspase-14 Antibody: Caspases are a family of cysteine proteases that can be divided into apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1b and IL-18. Caspase-14 is highly expressed in embryonic but not adult tissues. It is processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in the keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Antibody |
2509-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Caspase-14 Antibody: Caspases are a family of cysteine proteases that can be divided into apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1b and IL-18. Caspase-14 is highly expressed in embryonic but not adult tissues. It is processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in the keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Antibody |
3011-100 |
Biovision |
each |
EUR 405.6 |
Caspase-14 Antibody |
3011-30T |
Biovision |
each |
EUR 175.2 |
Caspase-14 Antibody |
49263-100ul |
SAB |
100ul |
EUR 399.6 |
Caspase-14 Antibody |
49263-50ul |
SAB |
50ul |
EUR 286.8 |
Caspase-14 Antibody |
AF9035 |
Affbiotech |
200ul |
EUR 420 |
Caspase-14 Antibody |
AF9035-100ul |
Affinity Biosciences |
100ul |
EUR 168 |
|
Description: WB,IHC,ELISA(peptide) |
Caspase-14 Antibody |
AF9035-200ul |
Affinity Biosciences |
200ul |
EUR 210 |
|
Description: WB,IHC,ELISA(peptide) |
Caspase-14 Antibody |
E18-9035-1 |
EnoGene |
50ug/50ul |
EUR 145 |
Description: Available in various conjugation types. |
Caspase-14 Antibody |
E18-9035-2 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Caspase-14 Antibody |
L0148-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: Caspase-14 Rabbit Polyclonal Antibody |
Caspase-14 Antibody |
L0148-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: Caspase-14 Rabbit Polyclonal Antibody |
Caspase-14 Antibody |
MBS151361-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Caspase-14 Antibody |
MBS151361-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Caspase-14 Antibody |
MBS9602078-01mL |
MyBiosource |
0.1mL |
EUR 260 |
Caspase-14 Antibody |
MBS9602078-02mL |
MyBiosource |
0.2mL |
EUR 305 |
Caspase-14 Antibody |
MBS9602078-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
Caspase-14 Antibody |
MBS8513074-005mg |
MyBiosource |
0.05mg |
EUR 235 |
Caspase-14 Antibody |
MBS8513074-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Caspase-14 Antibody |
MBS8513074-01mLAF405M |
MyBiosource |
0.1mL(AF405M) |
EUR 465 |
Caspase-14 Antibody |
MBS8513074-01mLAF546 |
MyBiosource |
0.1mL(AF546) |
EUR 465 |
Caspase-14 Antibody |
MBS8513074-01mLAF750 |
MyBiosource |
0.1mL(AF750) |
EUR 465 |
Caspase-14 Antibody |
MBS9436010-005mL |
MyBiosource |
0.05mL |
EUR 325 |
Caspase-14 Antibody |
MBS9436010-01mL |
MyBiosource |
0.1mL |
EUR 435 |
Caspase-14 Antibody |
MBS9436010-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1810 |
Caspase-14 Antibody |
MBS9410806-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Caspase-14 Antibody |
MBS9410806-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Polyclonal Caspase-14 Antibody |
APR06296G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-14 . This antibody is tested and proven to work in the following applications: |
Polyclonal Caspase-14 Antibody |
APR00002G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-14 . This antibody is tested and proven to work in the following applications: |
Caspase 14 (CASP14) Antibody |
abx339598-100l |
Abbexa |
100 µl |
EUR 350 |
Caspase 14 (CASP14) Antibody |
20-abx339598 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx339598-50l |
Abbexa |
50 µl |
EUR 250 |
Caspase 14 (CASP14) Antibody |
abx320171-100l |
Abbexa |
100 µl |
EUR 350 |
Caspase 14 (CASP14) Antibody |
20-abx320171 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx320171-50l |
Abbexa |
50 µl |
EUR 237.5 |
Caspase 14 (CASP14) Antibody |
abx323896-100g |
Abbexa |
100 µg |
EUR 250 |
Caspase 14 (CASP14) Antibody |
20-abx323896 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx323896-50g |
Abbexa |
50 µg |
EUR 187.5 |
Caspase 14 (CASP14) Antibody |
20-abx171604 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx171604-1ml |
Abbexa |
1 ml |
EUR 712.5 |
Caspase 14 (CASP14) Antibody |
abx171605-100l |
Abbexa |
100 µl |
EUR 775 |
Caspase 14 (CASP14) Antibody |
20-abx171605 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx171605-1ml |
Abbexa |
1 ml |
Ask for price |
Caspase 14 (CASP14) Antibody |
abx171605-200l |
Abbexa |
200 µl |
Ask for price |
Caspase 14 (CASP14) Antibody |
abx100900-100l |
Abbexa |
100 µl |
EUR 262.5 |
Caspase 14 (CASP14) Antibody |
20-abx100900 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 14 (CASP14) Antibody |
abx100900-1ml |
Abbexa |
1 ml |
EUR 687.5 |
Caspase 14 (CASP14) Antibody |
abx100900-200l |
Abbexa |
200 µl |
EUR 325 |
Caspase 14 (CASP14) Antibody |
abx005020-100l |
Abbexa |
100 µl |
EUR 400 |
Caspase 14 (CASP14) Antibody |
20-abx005020 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ul
- 50 ul
- 100 ul
- 200 ul
|
|
Caspase 14 (CASP14) Antibody |
abx005020-20l |
Abbexa |
20 µl |
EUR 175 |
Caspase 14 (CASP14) Antibody |
abx005020-50l |
Abbexa |
50 µl |
EUR 275 |
Caspase 14 (CASP14) Antibody |
abx148925-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Caspase 14 (CASP14) Antibody |
abx148925-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Caspase 14 (CASP14) Antibody |
abx148925-96tests |
Abbexa |
96 tests |
EUR 350 |
Caspase 14 (CASP14) Antibody |
abx211312-100l |
Abbexa |
100 µl |
EUR 350 |
Caspase 14 (CASP14) Antibody |
20-abx211312 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 (CASP14) Antibody |
abx211312-50l |
Abbexa |
50 µl |
EUR 250 |
Caspase 14 (CASP14) Antibody |
abx128917-100l |
Abbexa |
100 µl |
EUR 250 |
Caspase 14 (CASP14) Antibody |
20-abx128917 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 14 (CASP14) Antibody |
abx128917-1ml |
Abbexa |
1 ml |
EUR 675 |
Caspase 14 (CASP14) Antibody |
abx128917-200l |
Abbexa |
200 µl |
EUR 312.5 |
Caspase 14 (CASP14) Antibody |
abx129522-100l |
Abbexa |
100 µl |
EUR 262.5 |
Caspase 14 (CASP14) Antibody |
20-abx129522 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 14 (CASP14) Antibody |
abx129522-1ml |
Abbexa |
1 ml |
EUR 687.5 |
Caspase 14 (CASP14) Antibody |
abx129522-200l |
Abbexa |
200 µl |
EUR 325 |
Caspase 14 (CASP14) Antibody |
abx130380-100l |
Abbexa |
100 µl |
EUR 262.5 |
Caspase 14 (CASP14) Antibody |
20-abx130380 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 14 (CASP14) Antibody |
abx130380-1ml |
Abbexa |
1 ml |
EUR 725 |
Caspase 14 (CASP14) Antibody |
abx130380-200l |
Abbexa |
200 µl |
EUR 337.5 |
Caspase-14 Polyclonal Antibody |
ABP50016-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
ABP50016-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
ABP50016-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
BT-AP01197-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
Description: CASP14 encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. Caspase 14 has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of caspase 14 may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Polyclonal Antibody |
BT-AP01197-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
Description: CASP14 encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. Caspase 14 has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of caspase 14 may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Polyclonal Antibody |
BT-AP01197-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
Description: CASP14 encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. Caspase 14 has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of caspase 14 may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 polyclonal antibody |
BS8531 |
Bioworld Biotech |
50 ul |
EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
Caspase-14 polyclonal antibody |
BS90185 |
Bioworld Biotech |
50ul |
EUR 398 |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
Caspase-14 Conjugated Antibody |
C49263 |
SAB |
100ul |
EUR 476.4 |
Caspase-14 Polyclonal Antibody |
E20-10023 |
EnoGene |
100ug |
EUR 225 |
Description: Available in various conjugation types. |
Caspase-14 Polyclonal Antibody |
E44H00023 |
EnoGene |
100ul |
EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Caspase-14 Polyclonal Antibody |
E-AB-61201-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
Description: Unconjugated |
Caspase-14 Polyclonal Antibody |
E-AB-61201-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
Description: Unconjugated |
Caspase-14 Polyclonal Antibody |
E-AB-61201-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
Description: Unconjugated |
Caspase-14 Polyclonal Antibody |
E-AB-61201-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
Caspase-14 Polyclonal Antibody |
JOT-AP01197-100ul |
Jotbody |
100ul |
EUR 220 |
|
Description: Human |
Caspase-14 Polyclonal Antibody |
JOT-AP01197-50ul |
Jotbody |
50ul |
EUR 144 |
|
Description: Human |
Caspase-14 Polyclonal Antibody |
MBS2539844-002mL |
MyBiosource |
0.02mL |
EUR 140 |
Caspase-14 Polyclonal Antibody |
MBS2539844-006mL |
MyBiosource |
0.06mL |
EUR 180 |
Caspase-14 Polyclonal Antibody |
MBS2539844-012mL |
MyBiosource |
0.12mL |
EUR 260 |
Caspase-14 Polyclonal Antibody |
MBS2539844-02mL |
MyBiosource |
0.2mL |
EUR 405 |
Caspase-14 Polyclonal Antibody |
MBS9241227-01mL |
MyBiosource |
0.1mL |
EUR 415 |
Caspase-14 Polyclonal Antibody |
MBS9241227-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
Caspase-14 Polyclonal Antibody |
MBS8519039-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Caspase-14 Polyclonal Antibody |
MBS8519039-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
Caspase-14 Polyclonal Antibody |
MBS8519039-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
Caspase-14 Polyclonal Antibody |
MBS8519039-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
Caspase-14 Polyclonal Antibody |
MBS8519039-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
Caspase-14 Conjugated Antibody |
MBS9456914-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
Caspase-14 Conjugated Antibody |
MBS9456914-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
Caspase-14 Conjugated Antibody |
MBS9456914-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
Caspase-14 Conjugated Antibody |
MBS9456914-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
Caspase-14 Conjugated Antibody |
MBS9456914-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
Caspase-14 Polyclonal Antibody |
RD83884A-120uL |
Reddot Biotech |
120μL |
EUR 360 |
|
Description: This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Polyclonal Antibody |
RD83884A-200uL |
Reddot Biotech |
200μL |
EUR 630 |
|
Description: This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Polyclonal Antibody |
RD83884A-60uL |
Reddot Biotech |
60μL |
EUR 204 |
|
Description: This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. |
Caspase-14 Polyclonal Antibody |
UB-GEN-11 |
UpingBio |
100 ul |
EUR 200 |
Caspase 14 p10 antibody |
70R-50903 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal Caspase 14 p10 antibody |
Caspase 14 p10 Antibody |
20-abx008233 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Caspase 14 p10 Antibody |
MBS5315521-01mL |
MyBiosource |
0.1mL |
EUR 470 |
Caspase 14 p10 Antibody |
MBS5315521-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1955 |
CASPASE-14 Antibody (C-term) |
GWB-7F1AB7 |
GenWay Biotech |
0.1 mg |
Ask for price |
Polyclonal Antibody to Caspase-14 |
MBS668571-005mL |
MyBiosource |
0.05mL |
EUR 360 |
Polyclonal Antibody to Caspase-14 |
MBS668571-5x005mL |
MyBiosource |
5x0.05mL |
EUR 1600 |
Caspase 14 (CASP14) Antibody Pair |
abx370399-100g |
Abbexa |
100 µg |
EUR 1437.5 |
Caspase 14 (CASP14) Antibody Pair |
20-abx370399 |
Abbexa |
-
Ask for price
-
Ask for price
|
- 5 × 96 tests
- 10 × 96 tests
|
|
Electron microscopy additional revealed that left ventricles of pups at PND<em>14</em> after e-cigarette publicity exhibited apoptotic nuclei, convoluted nuclear membranes, myofibrillar derangement, and enlarged mitochondria sometimes displaying indicators of crystolysis, indicative of cardiomyopathy and cardiac dysfunction. Our outcomes present profound adversarial results of prenatal publicity of e-cigarette plus HFD in neonatal hearts that will result in long-term adversarial cardiac penalties within the grownup.